Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

<p>Supplementary Table 3 Uni- and multivariate Cox survival analysis using HJURP and NSD2 expression in myeloma dataset</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Yunlu Jia (2012017) (author)
Diğer Yazarlar:	Jianbiao Zhou (14935538) (author), Tze King Tan (15203447) (author), Tae-Hoon Chung (4343) (author), Yongxia Chen (424187) (author), Jing-Yuan Chooi (4238347) (author), Takaomi Sanda (15203450) (author), Melissa J. Fullwood (14195681) (author), Sinan Xiong (6175022) (author), Sabrina H.M. Toh (15203453) (author), Kalpnaa Balan (15203456) (author), Regina W.J. Wong (15203459) (author), Julia S.L. Lim (14935541) (author), Enfan Zhang (9965455) (author), Zhen Cai (576458) (author), Peng Shen (688111) (author), Wee Joo Chng (14959944) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Biology Molecular and Cellular Biology Gene Regulation Mechanisms of transcription Hematological Cancers Myelomas Oncogenes & Tumor Suppressors Oncogenes
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Table 1 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
Yazar:: Yunlu Jia (2012017)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
Yazar:: Yunlu Jia (2012017)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 5 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
Yazar:: Yunlu Jia (2012017)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S1-14 from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple <i>PIK3CA</i> Mutations
Yazar:: Smruthy Sivakumar (15053536)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Yazar:: Lijun Yao (15292963)
Baskı/Yayın Bilgisi: (2025)

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Yazar:: Lijun Yao (15292963)
Baskı/Yayın Bilgisi: (2025)

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Yazar:: Lijun Yao (15292963)
Baskı/Yayın Bilgisi: (2025)

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Yazar:: Lijun Yao (15292963)
Baskı/Yayın Bilgisi: (2025)

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Yazar:: Lijun Yao (15292963)
Baskı/Yayın Bilgisi: (2025)

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Yazar:: Lijun Yao (15292963)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Yazar:: Keiji Kurata (15055090)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Yazar:: Keiji Kurata (15055090)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Yazar:: Keiji Kurata (15055090)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan
Yazar:: Kazuhito Suzuki (22688384)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Yazar:: Feng Wang (44414)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Yazar:: Feng Wang (44414)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Yazar:: Feng Wang (44414)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Yazar:: Feng Wang (44414)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie 1 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
Yazar:: Jia Liu (15386858)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S1 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S1 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S1 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S1 page4 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S2 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S2 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S2 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Figure S3 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Yazar:: Craig M. Goodwin (14955973)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3rn5f00laif4a60t95v669jiti